Literature DB >> 1269837

Differential sensitivity of glycogenolysis and gluconeogenesis to insulin infusions in dogs.

J L Chiasson, J E Liljenquist, F E Finger, W W Lacy.   

Abstract

The suppressive effect of insulin on hepatic glucose production is generally recognized. Though it is well established that this effect is at least partially due to inhibition of glycogenolysis, controversy still exists about insulin's effect on gluconeogenesis. The present study was undertaken to determine whether insulin could affect gluconeogenesis from alanine in the intact dog and to compare the effect of insulin on glycogenolysis and gluconeogenesis. In anesthetized dogs fasted overnight, blood samples were drawn simultaneously from a femoral artery and hepatic vein. Alanine-U-14C, 10 mu Ci./kg., was infused over 110 minutes. A constant insulin infusion at either 1 or 5 mU./kg./min. was begun at 50 minutes, and blood glucose concentration was maintained by a variable glucose infusion. When insulin was infused at 1 mU./kg./min., resulting in plasma immunoreactive insulin (IRI) levels of 73 +/- 10 muU./ml., the net splanchnic glucose production (NSGP) was suppressed from 2.7 +/- 2 mg./kg./min. to virtually zero. In constrast, this small increment in insulin concentration had no demonstrable effect on the net splanchnic uptake of alanine or on the conversion of plasma alanine to glucose (7.9 +/- 0.3 mu mol/min.). Insulin infused at 5 mU./kg./min. resulted in IRI levels of 240 +/- 25 muU./ml. This higher insulin concentration was associated with a marked suppression of both the NSGP (100 per cent) and the conversion of plasma alanine to glucose (90 per cent) but did not affect the extraction of alanine by the splanchnic bed. Doses of both 1 and 5 mU./kg./min. were associated with a 35 per cent fall in immunoreactive glucagon levels. These data demonstrate that (1) glycogenolysis is more sensitive than gluconeogenesis to the inhibitory effect of small increments in insulin concentrations, (2) gluconeogenesis could be suppressed by insulin but only at higher insulin concentrations, (3) this suppression of gluconeogenesis from alanine by insulin was due to an intrahepatic effect rather than an effect on the splanchnic extraction of alanine, and finally, (4) that insulin can suppress glucagon in the absence of hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1269837     DOI: 10.2337/diab.25.4.283

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

1.  Intraportal glucose delivery alters the relationship between net hepatic glucose uptake and the insulin concentration.

Authors:  S R Myers; O P McGuinness; D W Neal; A D Cherrington
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

2.  Evidence that insulin can directly inhibit hepatic glucose production.

Authors:  P Maheux; Y D Chen; K S Polonsky; G M Reaven
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

3.  Blood lactate behavior after glucose load in diabetes mellitus.

Authors:  R Prando; V Cheli; P Buzzo; P Melga; E Ansaldi; S Accoto
Journal:  Acta Diabetol Lat       Date:  1988 Jul-Sep

4.  Influence of a 60-hour fast on insulin-mediated splanchnic and peripheral glucose metabolism in humans.

Authors:  O Björkman; L S Eriksson
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

5.  Excessive glucose production, rather than insulin resistance, accounts for hyperglycaemia in recent-onset streptozotocin-diabetic rats.

Authors:  R Burcelin; M Eddouks; J Maury; J Kande; R Assan; J Girard
Journal:  Diabetologia       Date:  1995-03       Impact factor: 10.122

6.  Alterations in alanine metabolism in diabetic dogs during short-term treatment with an artificial B cell.

Authors:  E J Freyse; U Fischer; G Albrecht; E Salzsieder
Journal:  Diabetologia       Date:  1985-10       Impact factor: 10.122

7.  Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.

Authors:  J E Liljenquist; G L Mueller; A D Cherrington; U Keller; J M Perry; W W Lacy; D Rabinowitz
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

8.  Differential effects of insulin deficiency on albumin and fibrinogen synthesis in humans.

Authors:  P De Feo; M G Gaisano; M W Haymond
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

9.  Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats.

Authors:  Esben S Buhl; Susanne Neschen; Shin Yonemitsu; Joerg Rossbacher; Dongyan Zhang; Katsutaro Morino; Allan Flyvbjerg; Pascale Perret; Varman Samuel; Jung Kim; Gary W Cline; Kitt Falk Petersen
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-09-25       Impact factor: 4.310

10.  Effects of insulin on the metabolic control of hepatic gluconeogenesis in vivo.

Authors:  Dale S Edgerton; Christopher J Ramnanan; Carrie A Grueter; Kathryn M S Johnson; Margaret Lautz; Doss W Neal; Phillip E Williams; Alan D Cherrington
Journal:  Diabetes       Date:  2009-09-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.